Form 4 for INSP Inspire Medical Systems, Inc.

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001104659-23-022076 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2023-02-14	2023-02-13	INSP	Herbert Timothy P.	CEO, Pres, Dir	S - Sale	$275.05	-2,619	9,728	-21%	-$720.4K
D	2023-02-14	2023-02-10	INSP	Herbert Timothy P.	CEO, Pres, Dir	A - Grant	$0.00	+20.4K	20.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-13	S	D	2,619	$275.05	9,728	I By family trust	—	—	(F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.19, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.
2	Derivative	Employee Stock Option (Right to Buy)	2023-02-10	A	A	20,439	$0.00	20,439	D	$263.16 · — to 2033-02-10	20,439 Common Stock	(F7) The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.